Knockdown of CD44 decreased the adhesiveness of human colon cancer cells to HA, cancer colony-forming ability in soft agar assays, and xenograft tumorigenicity, while increasing susceptibility to etoposide-induced apoptosis (58). Here, CD44 is linked to malignant colon neoplasm.